Mallinckrodt Plc
(NYSE : MNK)

( )
MNK PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
AMRNAmarin Corp. Plc 24.50%4.981.6%$86.29m
JAZZJazz Pharmaceuticals Plc -4.07%95.682.3%$85.16m
VRXValeant Pharmaceuticals International, Inc. -11.32%13.7514.1%$80.91m
PRGOPerrigo Co. Plc -6.03%45.196.8%$78.90m
CTLTCatalent, Inc. -7.68%47.962.2%$68.67m
UTHRUnited Therapeutics Corp. -0.98%93.9014.3%$68.29m
AXSMAxsome Therapeutics, Inc. -5.17%55.791.9%$64.25m
ICLRICON plc -2.79%132.204.2%$63.45m
HZNPHorizon Therapeutics Plc 1.94%30.206.5%$62.30m
GWPHGW Pharmaceuticals Plc -2.94%85.006.2%$54.99m
ICPTIntercept Pharmaceuticals, Inc. -7.24%58.4016.8%$39.26m
SAGESAGE Therapeutics, Inc. -6.86%26.758.6%$35.10m
PBHPrestige Consumer Healthcare, Inc. 1.50%37.234.0%$32.56m
PCRXPacira Biosciences, Inc. -3.91%32.2210.4%$30.88m
ZGNXZogenix, Inc. -6.59%23.109.2%$30.31m

Company Profile

Mallinckrodt Plc is a global specialty pharmaceuticals company. It develops, manufactures, markets and distributes both branded and generic specialty pharmaceutical products and medical imaging agents. It operates through the Specialty Brands and Specialty Generics segments. The Specialty Brands segment includes branded medicines. The Specialty Generics segment relates to specialty generic drugs, active pharmaceutical ingredients, as well as external manufacturing. The company was founded by Gustavo Mallinckrodt, Otto Mallinckrodt and Edward Mallinckrodt in 1867 and is headquartered in Staines-Upon-Thames, the United Kingdom.